Albuquerque, NMNCT06934642Now EnrollingIRB Ready

MASLD Clinical Trial in Albuquerque, NM

Access cutting-edge masld treatment through this clinical trial at a research site in Albuquerque. Study-provided care at no cost to qualified participants.

Sponsored by University of New Mexico

Quick Self-Assessment

See if you qualify for this Albuquerque location

Preparing your pre-screening questions…

Expert Care in Albuquerque

Access masld specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related masld treatment provided free

Apply for This Albuquerque Location

Check if you qualify for this masld clinical trial in Albuquerque, NM

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Albuquerque

    Convenient for NM residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Albuquerque site if eligible
  4. 4Begin participation

About This MASLD Study in Albuquerque

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common cause of chronic liver disease worldwide and predominately affects individuals with overweight and obesity, as well as those with type 2 diabetes and cardiovascular disease. Tirzepatide is a medication used to treat type 2 diabetes and obesity. It has also been shown to help with MASLD. The purpose of this study is to study how tirzepatide affects the liver in patients with MASLD. Participants will be asked to: * Take tirzepatide for 12 months. * Come in for clinic visits every 3 months. * Have blood drawn at baseline, 6, and 12 months. * Complete a liver ultrasound at baseline and at 12 months.

Sponsor: University of New Mexico

Who Can Participate

Inclusion Criteria

Men and women
Diagnosis of MASLD based on the following criteria:
Presence of at least 1 out of the 5 following cardiometabolic criteria:
BMI \>25 kg/m2 OR waist circumference \>94 cm (men) or 80cm (women)
Fasting serum glucose \>100 mg/dL OR 2-hour post-prandial glucose levels \>140mg/dL OR AbA1c \>5.7% OR type 2 diabetes OR treatment for type 2 diabetes
Blood pressure \>130/85 mmHg OR specific antihypertensive drug treatment
Plasma triglycerides \>150mg/dL OR on lipid lowering treatment
Plasma HDL-cholesterol \<40mg/dL (men) and \<50mg/dL (women) OR on lipid lowering medication
No other identified causes of steatosis
Evidence of steatotic liver disease (hepatic steatosis identified by imaging or biopsy)
English speaking

Exclusion Criteria

Pregnancy or breast feeding
Premenopausal women not on any form of contraception
Reports alcohol intake \>50g/day or 350g/week for women and \>60g/day or 420g/week for men or an AUDIT score \>8
Other identifiable causes of steatosis
Documented allergic reaction to tirzepatide or any other GLP1 RA
Decompensated liver disease
Decompensated renal disease requiring hemodialysis
Decompensated heart failure
Active malignancy
Prior history of pancreatitis
Serum triglyceride levels \>500 mg/dL
Personal or family history of medullary thyroid cancer or MEN2a or MEN2b
Concurrent use of other ant-obesity medications
Use of other GLP1 RAs within 3 months of study enrollment
Unable to obtain the medication due to cost or insurance coverage restrictions.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Albuquerque?

Yes, this clinical trial (NCT06934642) has an active research site in Albuquerque, NM that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

MASLD Treatment Options in Albuquerque, NM

If you're searching for masld treatment options in Albuquerque, NM, this clinical trial (NCT06934642) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Albuquerque research site is actively enrolling participants for this clinical trial. You'll receive care from experienced masld specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all masld clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Albuquerque, NM

See all ankylosing spondylitis clinical trials recruiting in Albuquerque — not just this study.

Browse Ankylosing Spondylitis Trials in Albuquerque →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsNon-Alcoholic Fatty Liver Disease TrialsAll Conditions →

Ready to Join in Albuquerque?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Albuquerque, NM